financetom
Business
financetom
/
Business
/
MUFG Expects SNB to Hold Rates as Swiss Franc Strength Persists
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
MUFG Expects SNB to Hold Rates as Swiss Franc Strength Persists
Sep 22, 2025 4:24 AM

06:47 AM EDT, 09/22/2025 (MT Newswires) -- The Swiss franc (CHF) has held firm over the past month even as global investor risk sentiment improved and equity markets hit fresh records, MUFG said.

USD/CHF briefly touched a year-to-date low of 0.7829 on Sept. 17, while EUR/CHF slid toward the bottom of its recent 0.9300-0.9400 range, the bank wrote in a client note.

Franc strength remains persistent this year and is likely to concern the Swiss National Bank because inflation is well below its 2% target, MUFG said.

The currency suffered a brief setback in mid-August after former U.S. president Donald Trump announced a 39% tariff on Swiss imports, with EUR/CHF spiking to 0.9457 on Aug. 18. Selling was driven by speculation that the higher tariffs might prompt the SNB to reconsider negative rates.

However, expectations for a return to negative rates have since receded ahead of Thursday's SNB policy meeting. MUFG noted that officials, including President Martin Schlegel, have signaled a high bar for re-imposing negative rates because of their side effects. Recent U.S.-Swiss trade talks have also raised hopes for a lower tariff rate.

As a result, MUFG does not expect this week's SNB decision to weaken the franc.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Pfizer to Acquire Metsera and its Next-Generation Obesity Portfolio
BRIEF-Pfizer to Acquire Metsera and its Next-Generation Obesity Portfolio
Sep 22, 2025
Sept 22 (Reuters) - Metsera Inc ( MTSR ): * PFIZER TO ACQUIRE METSERA AND ITS NEXT-GENERATION OBESITY PORTFOLIO * PFIZER INC ( PFE ) - DEAL VALUED AT $4.9 BILLION, $47.50 PER SHARE * PFIZER ( PFE ) - PROPOSED ACQUISITION TO ADD FOUR HIGHLY DIFFERENTIATED CLINICAL-STAGE INCRETIN AND AMYLIN PROGRAMS TO PFIZER'S PIPELINE * PFIZER ( PFE ):...
Exclusive-Bezos-backed renewables alliance targets $7.5 billion for developing countries
Exclusive-Bezos-backed renewables alliance targets $7.5 billion for developing countries
Sep 22, 2025
LONDON (Reuters) -An alliance that installs renewable energy in developing countries wants to invest around $7.5 billion during its next five-year plan, executives told Reuters, and is seeking more philanthropic partners as richer nations cut government aid. The Global Energy Alliance for People and Planet, launched at global climate talks in 2021, has helped 30-plus countries to enhance electricity grids,...
MUFG Expects SNB to Hold Rates as Swiss Franc Strength Persists
MUFG Expects SNB to Hold Rates as Swiss Franc Strength Persists
Sep 22, 2025
06:47 AM EDT, 09/22/2025 (MT Newswires) -- The Swiss franc (CHF) has held firm over the past month even as global investor risk sentiment improved and equity markets hit fresh records, MUFG said. USD/CHF briefly touched a year-to-date low of 0.7829 on Sept. 17, while EUR/CHF slid toward the bottom of its recent 0.9300-0.9400 range, the bank wrote in a...
Pfizer to buy weight-loss drug developer Metsera for up to $4.9 billion
Pfizer to buy weight-loss drug developer Metsera for up to $4.9 billion
Sep 22, 2025
Sept 22 (Reuters) - Pfizer ( PFE ) said on Monday it would acquire weight-loss drug developer Metsera ( MTSR ) for up to $4.9 billion to secure its position in the lucrative obesity treatment market. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved